The IDH1 enzyme functions as a dimer of two IDH1 proteins and only one of the two proteins is mutated, since a dimer of two mutated proteins is nearly completely inactive and may not confer a survival advantage to the glioma cell [43]. This evidence concerns the gene IDH1 and central nervous system cancer.